Qualcomm announces Snapdragon 865 Plus, will power ASUS, Lenovo devices
by Maria Thomas
Updated Jul 08, 2020
According to the company, the new Snapdragon 865 Plus is designed to deliver increased performance across the board for superior gameplay and insanely fast Qualcomm Snapdragon Elite Gaming experiences, truly global 5G, and ultraintuitive AI.
"ASUS is excited to once again offer users the best possible mobile gaming experience with the next generation ROG Phone 3, which will be powered by the new Snapdragon 865 Plus Mobile Platform," Bryan Chang, general manager of smartphone business unit, ASUS, said in a statement.
With a full arsenal of Snapdragon Elite Gaming premium features, Snapdragon 865 Plus aims to deliver desktop quality gaming with first-to-mobile features like updatable GPU drivers and desktop forward rendering, 5G gameplay at speed of up to 144 fps, and True 10-bit HDR gaming in over a billion shades of colour.
"Three years after the launch of the Lenovo Legiona, c PC portfolio, we're bringing our beloved gaming sub-brand's core values of speed and powerful performance to 5G mobile gaming - where Lenovo Legion will be amongst the first to offer the new Snapdragon 865 Plus in our expanding family of gaming devices this year," Jerry Tsao, vice president of Lenovo's Mobile Gaming Group Emerging Markets added.
Commercial devices based on Snapdragon 865 Plus are expected to be announced in the third quarter of 2020.
Related Articles
- Optical Illusion Brain Test: If you have Sharp Eyes Find the Number 442 in 20 Secs
- London-based firm Nothing to release its Phone (2)
- Covid will continue to cause mini-waves, not become seasonal yet: Scientists
- Hackers offering crypto accounts for as low as $30 on darknet
- Reddit's new feature to allow users to share its content on other platforms
- Surgical masks can help kids fight respiratory infections: Study
- LinkedIn's new AI feature to write messages to hiring team
- Microsoft introduces Xbox Game Pass' new Friend Referral programme
- Disbursed over Rs 31 cr in claims to delivery partners in FY22-23: Swiggy
- India emerging as favourable destination for clinical trials: Report